SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-044195
Filing Date
2020-04-07
Accepted
2020-04-07 16:30:57
Documents
8
Period of Report
2020-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2015227-1_8k.htm 8-K 29865
2 EXHIBIT 4.1 tm2015227d1_ex4-1.htm EX-4.1 112617
3 EXHIBIT 4.2 tm2015227d1_ex4-2.htm EX-4.2 116729
4 EXHIBIT 4.3 tm2015227d1_ex4-3.htm EX-4.3 29242
5 EXHIBIT 4.4 tm2015227d1_ex4-4.htm EX-4.4 87999
6 EXHIBIT 10.1 tm2015227d1_ex10-1.htm EX-10.1 138935
7 EXHIBIT 99.1 tm2015227d1_ex99-1.htm EX-99.1 13939
8 GRAPHIC tm2015227d1_ex99-1img01.jpg GRAPHIC 11310
  Complete submission text file 0001104659-20-044195.txt   541000
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 20780058
SIC: 2836 Biological Products, (No Diagnostic Substances)